FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileIncannex Healthcare Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
IXHL
Incannex Healthcare Limited Stock AnalysisComprehensive stock analysis for Incannex Healthcare Limited (IXHL) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisIXHL
IXHL
Incannex Healthcare Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
IXHL
  1. Home
  2. Stocks
  3. Incannex Healthcare Limited

Incannex Healthcare Limited

🇺🇸IXHL•NASDAQ

Incannex Healthcare Limited

🇺🇸IXHL•NASDAQ
Market cap
$22.25M

Your view on IXHL

Mkt Cap
$22.25M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Incannex Healthcare Limited

Industry
Biotechnology
Sector
Healthcare
CEO
Joel Bradley Latham
Headquarters
207/11 Solent Circuit, Sydney, NSW, AU
Industry
Biotechnology
Sector
Healthcare
CEO
Joel Bradley Latham
Headquarters
207/11 Solent Circuit, Sydney, NSW, AU
Description

Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name.

The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases.

It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion.

The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Incannex Healthcare Limited. Starting points for Incannex Healthcare Limited: EPS -$0.66, beta 2.84 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Incannex Healthcare Limited. Trailing twelve-month EPS for Incannex Healthcare Limited stands at -$0.66. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis quarterMar 2027Next quarterSep 2027This yearYear to Jun 2015Next yearYear to Jun 2021
Average estimate−$0.49−$0.57$11.31$11.31
Lowest estimate−$0.49−$0.57$11.31$11.31
Highest estimate−$0.49−$0.57$11.31$11.31
Number of analysts1111
A year ago−$0.571−$0.60——
Growth vs a year ago—+5.8%——

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterMar 2027Next quarterSep 2027This yearYear to Jun 2015Next yearYear to Jun 2021
Average estimate$30.00M$0.00$92.49M$92.49M
Lowest estimate$30.00M$0.00$92.49M$92.49M
Highest estimate$30.00M$0.00$92.49M$92.49M
Number of analysts1011
A year ago$86.00$0.00——
Growth vs a year ago+34883620.9%———

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Incannex Healthcare Limited. Incannex Healthcare Limited has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold IXHL20 companies · 1 funds
Compare IXHL with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
AGENAgenus Inc.HealthcareBiotechnology$270.1M
CGTXCognition Therapeutics, Inc.HealthcareBiotechnology$55.4M
IRDOpus Genetics, Inc.HealthcareBiotechnology$332.0M
LUCDLucid Diagnostics Inc.HealthcareMedical - Devices$72.6M
SCLXScilex Holding CompanyHealthcareDrug Manufacturers - General$4.0M
SEERSeer, Inc.HealthcareBiotechnology$75.9M
STSSSharps Technology, Inc.HealthcareMedical - Instruments & Supplies$53.7M
SXTCChina SXT Pharmaceuticals, Inc.HealthcareDrug Manufacturers - Specialty & Generic$14,124
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
NOX.AXNoxopharm LimitedHealthcareASX—
NRIXNurix Therapeutics, Inc.HealthcareNASDAQ$1.4B
NRSNNeuroSense Therapeutics Ltd.HealthcareNASDAQ$2.4M
NRSNWNeuroSense Therapeutics Ltd.HealthcareNASDAQ$120,867
NRX.VNurExone Biologic Inc.HealthcareTSXV—
NRXBFNurExone Biologic Inc.HealthcareOTC—
NRXPNRx Pharmaceuticals, Inc.HealthcareNASDAQ$95.3M
NRXSNeurAxis, Inc.HealthcareAMEX$59.9M
NSB.AXNeuroScientific Biopharmaceuticals LimitedHealthcareASX—
NSHS.CNNanoSphere Health Sciences Inc.HealthcareCNQ$256,880
NSHSFNanoSphere Health Sciences Inc.HealthcareOTC$102,752
NTHINeonc Technologies Holdings, Inc.HealthcareNASDAQ$90.9M
ETFs holding Incannex Healthcare Limited
TickerFundFund assets% of the fund
PSILAdvisorShares Psychedelics ETF$42M in assets0.80%

Largest holders first, then the funds most concentrated in IXHL.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Incannex Healthcare Limited, and how their positions are changing. At a $22.3M market value, institutional positions materially move Incannex Healthcare Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Incannex Healthcare Limited executives and directors. Shares of Incannex Healthcare Limited have traded between $0.08 and $2.25 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Incannex Healthcare Limited. Coverage tracks Incannex Healthcare Limited within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Incannex Healthcare Limited.

IXHL AnalysisFair
Past
1
Growth
2
Health
5
Profit
1
Value
1